BILL NUMBER: AB 1330	INTRODUCED
	BILL TEXT


INTRODUCED BY   Assembly Member Evans

                        FEBRUARY 23, 2007

   An act to add Section 16519 to the Welfare and Institutions Code,
relating to child welfare.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 1330, as introduced, Evans. Foster children: psychotropic
drugs: data.
   Existing law provides for oversight by various state and local
entities of certain populations of children, including those who are
dependent children or wards of the juvenile court, and those who are
in foster care, or are otherwise under the supervision of county
welfare departments.
   Existing law provides for a system of child welfare services
administered by each county, with oversight by the State Department
of Social Services.
   This bill would require the State Department of Social Services to
collect and maintain specified information regarding foster youth
who are prescribed psychotropic medication, and to monitor whether
those youth receive appropriate medical care and supervision before
and after the prescription of the psychotropic medication, in
accordance with the recommendations made for the medication by the
federal Food and Drug Administration.
   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 16519 is added to the Welfare and Institutions
Code, to read:
   16519.  (a) The State Department of Social Services shall collect
and maintain the following information regarding each foster youth
who is prescribed a psychotropic medication, as defined in
subdivision (d) of Section 369.5:
   (1) The youth's sex, age, and ethnicity or race.
   (2) The number of years the youth has been in the foster care
system.
   (3) The type of placement within the system, such as foster
family, group home, or juvenile justice system.
   (4) The type of drug prescribed.
   (b) The department shall monitor whether each youth for whom
information is collected pursuant to subdivision (a) receives
appropriate medical care and supervision before and after the
prescription of the psychotropic medication, in accordance with the
recommendations made for the medication by the federal Food and Drug
Administration.